Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Beier, Fabian  [Clear All Filters]
2024
Ben Hamza A, Welters C, Stadler S, Brüggemann M, Dietze K, Brauns O, Brümmendorf TH, Winkler TH, Bullinger L, Blankenstein T, et al. Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry. Blood. 2024.
2023
Vieri M, Tharmapalan V, Kalmer M, Baumeister J, Nikolić M, Schnitker M, Kirschner M, Flosdorf N, de Toledo MAS, Zenke M, et al. Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms. Blood Cancer J. 2023;13(1):164.
Hakkarainen M, Kaaja I, Douglas SPM, Vulliamy TJ, Dokal I, Soulier J, Larcher L, de Latour RPeffault, Leblanc TM, de Fontbrune FSicre, et al. The Clinical Picture of the ERCC6L2 Disease - from Bone Marrow Failure to Acute Leukemia. Blood. 2023.
Sharma R, Oak N, Chen W, Gogal R, Kirschner M, Beier F, Schnieders MJ, Spies M, Nichols KE, Wlodarski M. Germline landscape of variants in pediatric malignancies: identification of as a novel cancer predisposition candidate gene. Front Oncol. 2023;13:1229507.
Tometten M, Kirschner M, Meyer R, Begemann M, Halfmeyer I, Vieri M, Kricheldorf K, Maurer A, Platzbecker U, Radsak M, et al. Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria. Hemasphere. 2023;7(5):e874.
Jacobi H, Vieri M, Bütow M, Namasu CY, Flüter L, Costa IG, Maié T, Lindemann-Docter K, Chatain N, Beier F, et al. Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients. Front Pharmacol. 2023;14:1212392.
Griffin M, Eikema D-J, Verheggen I, Kulagin A, Tjon JM-L, Fattizzo B, Ingram W, Zaidi U, Desnica L, Giammarco S, et al. SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria. Haematologica. 2023.
Bernardinello N, Crestani B, Spagnolo P, Ghanem M, Homps-Legrand M, Morer L, Goletto T, Frija-Masson J, Bancal C, Hurtado-Nedelec M, et al. Is telomere length a predictor of long-term survival in patients with COVID-19 pneumonia?. Respir Med Res. 2023;84:101048.
Rolles B, Ferreira MSV, Vieri M, Rheinwalt KP, Schmitz SM, Alizai PH, Neumann U, Brümmendorf TH, Beier F, Ulmer TF, et al. Telomere length dynamics measured by flow-FISH in patients with obesity undergoing bariatric surgery. Sci Rep. 2023;13(1):304.
2021
Crysandt M, Soysal H, Jennes E, Holtick U, Mrotzek M, Rehnelt S, Holderried TAW, Wessiepe M, Kunter U, Wilop S, et al. Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility. Eur J Haematol. 2021.
2020
Boettcher S, C Wilk M, Singer J, Beier F, Burcklen E, Beisel C, Ferreira MSVentura, Gourri E, Gassner C, Frey BM, et al. Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation. Blood. 2020.
2019
Iberl S, Meyer A-L, Müller G, Peters S, Johannesen S, Kobor I, Beier F, Brümmendorf TH, Hart C, Schelker R, et al. Effects of continuous high-dose G-CSF administration on hematopoietic stem cell mobilization and telomere length in patients with amyotrophic lateral sclerosis - a pilot study. Cytokine. 2019;120:192-201.
2018
Crysandt M, Brings K, Beier F, Thiede C, Brümmendorf TH, Jost E. Germline predisposition to myeloid malignancies appearing in adulthood. Expert Rev Hematol. 2018.
Andert A, Alizai HP, Ulmer TFlorian, Heidenhain C, Ziegler P, Brümmendorf TH, Neumann UPeter, Beier F, Klink CD. Influence of Telomere Length in Hepatocytes on Liver Regeneration after Partial Hepatectomy in Rats. Eur Surg Res. 2018;59(1-2):83-90.
2016
Schneider RK, Schenone M, Ferreira MVentura, Kramann R, Joyce CE, Hartigan C, Beier F, Brümmendorf TH, Germing U, Platzbecker U, et al. Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9. Nat Med. 2016.
2015
Stockklausner C, Raffel S, Klermund J, Bandapalli OReddy, Beier F, Brümmendorf TH, Bürger F, Sauer SW, Hoffmann GF, Lorenz H, et al. A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition. Aging (Albany NY). 2015.